{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:15:33Z","timestamp":1781201733204,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00228-019-02749-3","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T16:25:48Z","timestamp":1567009548000},"page":"1675-1683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome"],"prefix":"10.1007","volume":"75","author":[{"given":"Eva","family":"Cuzzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Franca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"De Iudicibus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Marcuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Lucaf\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Favretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Ghio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"La Scola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mencarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9714-6246","authenticated-orcid":false,"given":"Giuliana","family":"Decorti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Stocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"2749_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jsbmb.2010.02.018","volume":"120","author":"PJ Barnes","year":"2010","unstructured":"Barnes PJ (2010) Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 120:76\u201385. \nhttps:\/\/doi.org\/10.1016\/j.jsbmb.2010.02.018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2749_CR2","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","volume":"373","author":"PJ Barnes","year":"2009","unstructured":"Barnes PJ, Adcock IM (2009) Glucocorticoid resistance in inflammatory diseases. Lancet 373:1905\u20131917. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(09)60326-3","journal-title":"Lancet"},{"key":"2749_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629\u2013639. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(03)14184-0","journal-title":"Lancet"},{"key":"2749_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1523-1755.2004.00392.x","volume":"65","author":"AP Carlotti","year":"2004","unstructured":"Carlotti AP, Franco PB, Elias LL, Facincani I, Costa EL, Foss N et al (2004) Glucocorticoid receptors, in vitro steroid sensitivity, and cytokine secretion in idiopathic nephrotic syndrome. Kidney Int 65:403\u2013408. \nhttps:\/\/doi.org\/10.1111\/j.1523-1755.2004.00392.x","journal-title":"Kidney Int"},{"key":"2749_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1365-2125.2011.04130.x","volume":"73","author":"E Cuzzoni","year":"2012","unstructured":"Cuzzoni E, De Iudicibus S, Bartoli F, Ventura A, Decorti G (2012) Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. Br J Clin Pharmacol 73:651\u2013655. \nhttps:\/\/doi.org\/10.1111\/j.1365-2125.2011.04130.x","journal-title":"Br J Clin Pharmacol"},{"key":"2749_CR6","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2217\/pgs.15.101","volume":"16","author":"E Cuzzoni","year":"2015","unstructured":"Cuzzoni E, De Iudicibus S, Franca R, Stocco G, Lucaf\u00f2 M, Pelin M et al (2015) Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome. Pharmacogenomics 16:1631\u20131648. \nhttps:\/\/doi.org\/10.2217\/pgs.15.101","journal-title":"Pharmacogenomics"},{"key":"2749_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00467-006-0026-5","volume":"21","author":"CE Araya","year":"2006","unstructured":"Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, Garin EH (2006) A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 21:603\u2013610. \nhttps:\/\/doi.org\/10.1007\/s00467-006-0026-5","journal-title":"Pediatr Nephrol"},{"key":"2749_CR8","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s004679900269","volume":"14","author":"EH Garin","year":"2000","unstructured":"Garin EH (2000) Circulating mediators of proteinuria in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 14:872\u2013878","journal-title":"Pediatr Nephrol"},{"key":"2749_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00859637","volume":"3","author":"HW Schnaper","year":"1989","unstructured":"Schnaper HW (1989) The immune system in minimal change nephrotic syndrome. Pediatr Nephrol 3:101\u2013110","journal-title":"Pediatr Nephrol"},{"key":"2749_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1677\/joe.0.1780339","volume":"178","author":"RJ Farrell","year":"2003","unstructured":"Farrell RJ, Kelleher D (2003) Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol 178:339\u2013346","journal-title":"J Endocrinol"},{"key":"2749_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/cpt.372","volume":"100","author":"E Cuzzoni","year":"2016","unstructured":"Cuzzoni E, De Iudicibus S, Stocco G, Favretto D, Pelin M, Messina G et al (2016) In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome. Clin Pharmacol Ther 100:268\u2013274. \nhttps:\/\/doi.org\/10.1002\/cpt.372","journal-title":"Clin Pharmacol Ther"},{"key":"2749_CR12","unstructured":"Becker LA. Effect size calculators [home page on the internet] UCCS University of Colorado. 03\/021\/00 [2018 July 6]. Available from: \nhttp:\/\/www.uccs.edu\/lbecker\/effect-size"},{"key":"2749_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1542\/peds.2008-1559","volume":"124","author":"DS Gipson","year":"2009","unstructured":"Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124:747\u2013757. \nhttps:\/\/doi.org\/10.1542\/peds.2008-1559","journal-title":"Pediatrics"},{"key":"2749_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/adc.83.1.45","volume":"83","author":"EM Hodson","year":"2000","unstructured":"Hodson EM, Knight JF, Willis NS, Craig JC (2000) Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials. Arch Dis Child 83:45\u201351","journal-title":"Arch Dis Child"},{"key":"2749_CR15","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1542\/peds.105.6.1242","volume":"105","author":"RJ Hogg","year":"2000","unstructured":"Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J (2000) Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the national kidney foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 105:1242\u20131249","journal-title":"Pediatrics"},{"key":"2749_CR16","doi-asserted-by":"publisher","first-page":"CD001533","DOI":"10.1002\/14651858.CD002290.pub3","volume":"3","author":"D Hahn","year":"2007","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC (2007) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 3:CD001533. \nhttps:\/\/doi.org\/10.1002\/14651858.CD002290.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"2749_CR17","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1186\/ar3828","volume":"14","author":"FF Wang","year":"2012","unstructured":"Wang FF, Zhu LA, Zou YQ, Zheng H, Wilson A, Yang CD, Shen N, Wallace DJ, Weisman MH, Chen SL, Lu LJ (2012) New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus. Arthritis Res Ther 14:R103. \nhttps:\/\/doi.org\/10.1186\/ar3828","journal-title":"Arthritis Res Ther"},{"key":"2749_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nri1200","volume":"3","author":"T Calandra","year":"2003","unstructured":"Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791\u2013800. \nhttps:\/\/doi.org\/10.1038\/nri1200","journal-title":"Nat Rev Immunol"},{"key":"2749_CR19","doi-asserted-by":"publisher","first-page":"7849","DOI":"10.1073\/pnas.93.15.7849","volume":"93","author":"M Bacher","year":"1996","unstructured":"Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R (1996) An essential regulatory role for macrophage migration inhibitory factor in t-cell activation. Proc Natl Acad Sci U S A 93:7849\u20137854","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/377068a0","volume":"377","author":"T Calandra","year":"1995","unstructured":"Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68\u201371. \nhttps:\/\/doi.org\/10.1038\/377068a0","journal-title":"Nature"},{"key":"2749_CR21","doi-asserted-by":"publisher","first-page":"R1043","DOI":"10.1152\/ajpregu.2000.279.3.R1043","volume":"279","author":"JM Daun","year":"2000","unstructured":"Daun JM, Cannon JG (2000) Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha. Am J Physiol Regul Integr Comp Physiol 279:R1043\u2013R1049. \nhttps:\/\/doi.org\/10.1152\/ajpregu.2000.279.3.R1043","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2749_CR22","doi-asserted-by":"publisher","first-page":"18100","DOI":"10.1074\/jbc.274.25.18100","volume":"274","author":"RA Mitchell","year":"1999","unstructured":"Mitchell RA, Metz CN, Peng T, Bucala R (1999) Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase a2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 274:18100\u201318106","journal-title":"J Biol Chem"},{"key":"2749_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/jcp.10272","volume":"195","author":"A Bevilacqua","year":"2003","unstructured":"Bevilacqua A, Ceriani MC, Capaccioli S, Nicolin A (2003) Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol 195:356\u2013372. \nhttps:\/\/doi.org\/10.1002\/jcp.10272","journal-title":"J Cell Physiol"},{"key":"2749_CR24","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1002\/eji.200535413","volume":"35","author":"T Roger","year":"2005","unstructured":"Roger T, Chanson AL, Knaup-Reymond M, Calandra T (2005) Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol 35:3405\u20133413. \nhttps:\/\/doi.org\/10.1002\/eji.200535413","journal-title":"Eur J Immunol"},{"key":"2749_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2008.09.014","volume":"399","author":"LL Santos","year":"2009","unstructured":"Santos LL, Morand EF (2009) Macrophage migration inhibitory factor: a key cytokine in ra, sle and atherosclerosis. Clin Chim Acta 399:1\u20137. \nhttps:\/\/doi.org\/10.1016\/j.cca.2008.09.014","journal-title":"Clin Chim Acta"},{"key":"2749_CR26","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B","volume":"42","author":"M Leech","year":"1999","unstructured":"Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF (1999) Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 42:1601\u20131608. \nhttps:\/\/doi.org\/10.1002\/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B","journal-title":"Arthritis Rheum"},{"key":"2749_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2119\/molmed.2008.00109","volume":"15","author":"A Bruchfeld","year":"2009","unstructured":"Bruchfeld A, Carrero JJ, Qureshi Lindholm B, Barany P, Heimburger O, Hu M et al (2009) Elevated serum macrophage migration inhibitory factor (mif) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation. Mol Med 15:70\u201375. \nhttps:\/\/doi.org\/10.2119\/molmed.2008.00109","journal-title":"Mol Med"},{"key":"2749_CR28","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s00467-005-1930-9","volume":"20","author":"A Berdeli","year":"2005","unstructured":"Berdeli A, Mir S, Ozkayin N, Serdaroglu E, Tabel Y, Cura A (2005) Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome. Pediatr Nephrol 20:1566\u20131571. \nhttps:\/\/doi.org\/10.1007\/s00467-005-1930-9","journal-title":"Pediatr Nephrol"},{"key":"2749_CR29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00467-007-0729-2","volume":"23","author":"M Vivarelli","year":"2008","unstructured":"Vivarelli M, D\u2019Urbano LE, Stringini G, Ghiggeri GM, Caridi G, Donn R et al (2008) Association of the macrophage migration inhibitory factor -173*C allele with childhood nephrotic syndrome. Pediatr Nephrol 23:743\u2013748. \nhttps:\/\/doi.org\/10.1007\/s00467-007-0729-2","journal-title":"Pediatr Nephrol"},{"key":"2749_CR30","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00467-011-1903-0","volume":"26","author":"HJ Choi","year":"2011","unstructured":"Choi HJ, Cho HY, Ro H, Lee SH, Han KH, Lee H, Kang HG, Ha IS, Choi Y, Cheong HI (2011) Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome. Pediatr Nephrol 26:1981\u20131988. \nhttps:\/\/doi.org\/10.1007\/s00467-011-1903-0","journal-title":"Pediatr Nephrol"},{"key":"2749_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1017\/S2040174415007850","volume":"7","author":"OR Ramayani","year":"2016","unstructured":"Ramayani OR, Sekarwana N, Trihono PP, Sadewa AH, Lelo A (2016) A genetic study of steroid-resistant nephrotic syndrome: relationship between polymorphism \u2212173 G to C in the MIF gene and serum level MIF in children. J Dev Orig Health Dis 7:102\u2013107. \nhttps:\/\/doi.org\/10.1017\/S2040174415007850","journal-title":"J Dev Orig Health Dis"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02749-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02749-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02749-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T23:13:34Z","timestamp":1598483614000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02749-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2749"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02749-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"assertion":[{"value":"21 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}